Please login to the form below

Not currently logged in
Email:
Password:

Merck & Co partners with International Diabetes Federation

Merck & Co and the International Diabetes Federation (IDF) will hold a number of "Unite for Diabetes" meetings in each of the seven IDF regions

US-based Merck & Co and the International Diabetes Federation (IDF) have revealed they will hold a number of "Unite for Diabetes" meetings in each of the seven IDF regions.

The meetings will help further achieve the goals of the United Nations (UN) Resolution for diabetes, including access to diabetes management strategies and appropriate treatment. It is estimated that up to 80 per cent of type 2 diabetes cases could be prevented.

Both entities say that the need for continued development of regional strategies, such as "Unite for Diabetes", for the prevention and management of diabetes is further supported by the results of a new global survey that looks at the reality of living with diabetes from the perspective of both the person with diabetes and the doctor.

The "Diabetes: The Real Picture" survey was commissioned and funded by Merck & Co, the results of which show some key similarities among countries worldwide with regard to the perception and management of type 2 diabetes.

The results highlighted a number of regional differences as well as demonstrating the difference in perceptions between people with diabetes and doctors regarding impact, management and treatment. These results further reinforce the need for regional meetings to bring key stakeholders together.

Research has shown that less than half of patients receiving therapy for their type 2 diabetes are at their HbA1c (blood glucose) goal, suggesting that current management strategies are inadequate in controlling this complex disease. The results from the survey further highlight the need for new strategies to help patients manage their diabetes, achieve glycaemic control and reduce side effects and complications.

The IDF Regional "Unite for Diabetes" meetings will take place during 2008/ 2009 and will focus directly on the UN Resolution to drive local government focus on the need to implement changes that address both policy and patient objectives.

Patient and professional groups will be invited to participate and help identify local capacity-building needs within each region to facilitate effective implementation of the UN Resolution for diabetes, while ensuring that the "voice of the patient" is represented.

30th September 2008

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
JPA Health

JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics